Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis

15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...

Read more →

Atomoxetine – further delay in change of funded brand and open access

10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...

Read more →

PBS – 2019 in review

9 January 2020 - 16 'real world' new medicines were listed on the PBS in 2019. ...

Read more →

New hope for breast cancer patients with key drug added to PBS

6 January 2020 - Australians living with advanced breast cancer now have access to an important new treatment option, with the ...

Read more →

New drug added to PBS can double life expectancy for breast cancer

5 January 2020 - A new drug that can slow the progression of advanced breast cancer has been added to the ...

Read more →

Schedule of Pharmaceutical Benefits - 1 January 2020 update

1 January 2020 - The January 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Biosimilar trastuzumab and rituximab on the PBS - information for health professionals and patients

2 January 2019 - New biosimilar brands of trastuzumab (Ontruzant) and rituximab (Truxima) have listed on the PBS on 1 January ...

Read more →

New laws that affect Australians from January 1, 2020

1 January 2020 - Today there are a raft of changes coming to welfare, health, education and many other living expenses. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 January 2020 update

2 January 2020 - The January 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Decision to fund two new cancer treatments: olaparib and fulvestrant

5 December 2019 - PHARMAC is pleased to announce a decision to fund two new cancer treatments and amend the ...

Read more →

Biosimilar trastuzumab on the PBS - information for health professionals and patients

2 December 2019 - A new biosimilar brand of trastuzumab (Kanjinti) has listed on the PBS on 1 December 2019.  ...

Read more →

Tasmanian man Robert Mitchell welcomes rollout of new drug Dovato on PBS

2 December 2019 - Robert Mitchell has been defying a medical diagnosis for nearly 30 years. Now a new drug will ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2019 update

1 December 2019 - The December 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New hope for psoriasis sufferers as new drug Skyrizi added to PBS

1 December 2019 - Australians living with severe chronic psoriasis have been given renewed hope with the introduction of a new ...

Read more →

New Zealand Pharmaceutical Schedule - 1 December 2019 update

1 December 2019 - The December 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →